Inventaire - your friends and communities are your best library

T cell defined tumor antigens

published in: Current Opinion in Immunology

date of publication: 1997-10-01

Cites articles 82

Date

Title

Authors

1997-01-01

The expression of mouse gene P1A in testis does not prevent safe induction of cytolytic T cells against a P1A-encoded tumor antigen.
1997-03-01

Melanoma antigen-encoding gene-1 expression in invasive gastric carcinoma: correlation with stage of disease
1997-01-01

Detection of MAGE-4 protein in sera of patients with head-and-neck squamous-cell carcinoma
1997-01-01

Expression of MAGE genes in osteosarcoma
1997-04-01

T cells recognize the VH complementarity-determining region 3 of the idiotypic protein of B cell non-Hodgkin's lymphoma
1997-03-21

Stabilization of beta-catenin by genetic defects in melanoma cell lines
1997-03-01

Beta-catenin as oncogene: the smoking gun.

Mark Peifer
1997-08-01

A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma

Susanna Mandruzzato
1997-02-01

Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor

Massimo Vitale
1997-02-01

Identification of Her-2/Neu CTL epitopes using double transgenic mice expressing HLA-A2.1 and human CD.8.

Linda A Sherman
1997-02-01

Implications for immunosurveillance of altered HLA class I phenotypes in human tumours
1997-02-01

Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma

Steven Rosenberg
1997-02-01

In vitro generation of human cytotoxic T lymphocytes specific for peptides derived from prostate-specific antigen
1997-02-01

The immunodominant antigen of an ultraviolet-induced regressor tumor is generated by a somatic point mutation in the DEAD box helicase p68

Victor H Engelhard
1996-02-01

An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins
1996-07-01

The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation

Isabella Faraoni
1996-11-01

Methylated CpG points identified within MAGE-1 promoter are involved in gene repression
1996-07-01

MAGE BAGE and GAGE genes expression in fresh epithelial ovarian carcinomas
1996-10-01

Expression of MAGE-1, MAGE-3 and MART-1 genes in neuroblastoma

Maria Valeria Corrias
1996-10-01

MAGE-1 and MAGE-3 or -6 expression in neuroblastoma-related pediatric solid tumors
1996-08-01

Expression of MAGE genes in human colorectal carcinoma
1996-07-01

Expression of the MAGE-1, -2, -3, -4, and -6 genes in non-squamous cell carcinoma lesions of the head and neck
1996-06-01

Infrequent expression of the MAGE gene family in uveal melanomas
1996-03-01

MAGE-1 gene is expressed in T-cell leukemia
1996-09

A new gene coding for an antigen recognized by autologous cytolytic T lymphocytes on a human renal carcinoma

Jean-Jacques Patard
1996-11-01

Making the most of mucin: a novel target for tumor immunotherapy

Simon Barratt Boyes
1996-12-01

Breast cancer-associated antigen, DF3/MUC1, induces apoptosis of activated human T cells

Gordon J. Freeman, Lee M. Nadler
1996-05-01

Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes

Steven Rosenberg
1996-03-01

Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen

Steven Rosenberg
1996-11-01

Carcinoembryonic antigen as a target for cancer vaccines
1996-03-01

A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes

Steven Rosenberg
1996-06-14

Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death

Article - wd:Q41642406

Welcome to Inventaire

the library of your friends and communities

learn more